OTC Markets OTCQB - Delayed Quote USD

AppYea, Inc. (APYP)

Compare
0.0137 0.0000 (0.00%)
At close: October 18 at 4:00 PM EDT
Loading Chart for APYP
DELL
  • Previous Close 0.0000
  • Open 0.0126
  • Bid 0.0125 x --
  • Ask 0.0150 x --
  • Day's Range 0.0121 - 0.0126
  • 52 Week Range 0.0111 - 0.1700
  • Volume 267,970
  • Avg. Volume 53,785
  • Market Cap (intraday) 6.529M
  • Beta (5Y Monthly) -0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Nov 14, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The company was founded in 2012 and is based in Gan Yavne, Israel.

www.appyea.com

9

Full Time Employees

December 31

Fiscal Year Ends

Recent News: APYP

View More

Performance Overview: APYP

Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APYP
8.40%
S&P 500
22.95%

1-Year Return

APYP
1.78%
S&P 500
34.10%

3-Year Return

APYP
96.73%
S&P 500
31.16%

5-Year Return

APYP
31.30%
S&P 500
95.62%

Compare To: APYP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APYP

View More

Valuation Measures

Annual
As of 10/18/2024
  • Market Cap

    6.53M

  • Enterprise Value

    8.67M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    321.07

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    578.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -293.36%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    15k

  • Net Income Avi to Common (ttm)

    -2.25M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    158k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.29M

Research Analysis: APYP

View More

Company Insights: APYP

Research Reports: APYP

View More

People Also Watch